Fat grafting and platelet-rich plasma in wound healing: a review of histology from animal studies.
Grant Switzer NolanOliver J SmithGavin JellAfshin MosahebiPublished in: Adipocyte (2021)
Stem cells could form the basis of a novel, autologous treatment for chronic wounds like diabetic foot ulcers. Fat grafts contain adipose-derived stem cells (ADSC) but low survival of cells within the grafts is a major limitation. Platelet-rich plasma (PRP) may increase graft survival. This review examines the histology from animal studies on fat grafting, ADSC and PRP in wound healing. A literature review of major electronic databases was undertaken, and narrative synthesis performed. Data from 30 animal studies were included. ADSC increase angiogenesis over 14 days and often clinically accelerated wound healing. ADSC had a greater effect in animals with impaired wound healing (e.g. diabetes). Activated PRP increased viability of fat grafts. Despite the high number of studies, the quality is variable which weakens the evidence. It does suggest there is a benefit of ADSC, particularly in impaired wound healing. High-quality evidence in humans is required, to establish its clinical usefulness.
Keyphrases
- wound healing
- platelet rich plasma
- adipose tissue
- stem cells
- case control
- fatty acid
- cardiovascular disease
- induced apoptosis
- type diabetes
- big data
- machine learning
- endoplasmic reticulum stress
- insulin resistance
- replacement therapy
- endothelial cells
- artificial intelligence
- glycemic control
- cell therapy
- skeletal muscle
- cell proliferation
- weight loss
- data analysis
- breast reconstruction
- pi k akt